Stocks Health care MCTA

NASDAQ · Health care

Charming Medical Ltd (MCTA)

Charming Medical Ltd reported revenue of $4.8M in fiscal 2026, down 22.7% from a year earlier. It posted a net loss of $22.6K. In fiscal 2026 capital spending exceeded operating cash flow by $1.6M. At March 31, 2026 it held $4.7M in cash against $185.8K of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on July 30, 2026.

Watch MCTA in 60 seconds

What Charming Medical Ltd does

Charming Medical Ltd is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on NASDAQ under the ticker MCTA.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Where MCTA ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Charming Medical Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. July 30, 2026
   Annual report (foreign issuer) 20-F · period to March 31, 2026Revenue fell 23% to $4.8M versus the prior year; diluted EPS $0.00 versus $0.08.
2. July 21, 2026
   Foreign issuer update 6-K
3. May 6, 2026
   Foreign issuer update 6-K
4. April 2, 2026
   Foreign issuer update 6-K
5. March 31, 2026
   Foreign issuer update 6-K
6. March 27, 2026
   Foreign issuer update 6-K
7. March 27, 2026
   Activist stake (5% or more) SCHEDULE 13D
8. January 6, 2026
   Foreign issuer update 6-K
9. November 28, 2025
   Foreign issuer update 6-K
10. November 13, 2025
    Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 3, the latest on March 27, 2026. Insider transactions on SEC

Who owns MCTA

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about MCTA

What does Charming Medical Ltd do?

Charming Medical Ltd is registered with the SEC under industry code SIC 8090 (Services-Misc Health & Allied Services, NEC). Its shares trade on NASDAQ under the ticker MCTA.

Is Charming Medical Ltd profitable?

No. In fiscal 2026 it reported a net loss of $22.6K on revenue of $4.8M.

How much revenue does Charming Medical Ltd make?

In fiscal 2026 Charming Medical Ltd reported revenue of $4.8M. That is 22.7% less than a year earlier.

When did Charming Medical Ltd last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on July 30, 2026. It covers the period to March 31, 2026.

Similar companies

Compare MCTA with

Compare MCTA with any company

Follow MCTA

Get an email when Charming Medical Ltd files with the SEC: results, executive changes, material agreements and annual reports.

Follow MCTA: get an email when it files

Where the numbers come from

Financial figures are the values Charming Medical Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.